Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

447 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, not recruiting

Premedication to Reduce Amivantamab Associated Infusion Related Reactions

NCT05663866

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Compassionate Cancer Care Fountain Valley, California, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
  • UW Medicine Valley Medical Center Renton, Washington, United States
  • CHU de Brest - Hopital de la Cavale Blanche Brest, France
View all 36 locations
View Trial Details
Active, not recruiting

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

NCT06116786

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • City of Hope 1 Newnan, Georgia, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Roswell Park Comprehensive Cancer Center Buffalo, New York, United States
  • Herbert Irving Comprehensive Cancer Center Columbia University Medical Center New York, United States
View all 15 locations
View Trial Details
Active, not recruiting

A Study to Learn About the Study Medicine PF-07934040 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Genetic Mutation.

NCT06447662

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +29 more
Locations
  • Highlands Oncology Group, PA Fayetteville, Arkansas, United States
  • Highlands Oncology Group, PA Rogers, Arkansas, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
View all 27 locations
View Trial Details
Active, not recruiting

Oleclumab (MEDI9447) Epidermal Growth Factor Receptor Mutant (EGFRm) Non-small Cell Lung Cancer (NSCLC) Novel Combination Study

NCT03381274

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Research Site La Jolla, California, United States
  • Research Site San Francisco, California, United States
  • Research Site Aurora, Colorado, United States
  • Research Site New Haven, Connecticut, United States
View all 13 locations
View Trial Details
Active, not recruiting

A Study of Repotrectinib Versus Crizotinib in Participants With Locally Advanced or Metastatic Tyrosine Kinase Inhibitor (TKI)-naïve ROS1-positive Non-Small Cell Lung Cancer (NSCLC) (TRIDENT-3)

NCT06140836

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Local Institution - 0221 Des Moines, Iowa, United States
  • Local Institution - 0075 Boston, Massachusetts, United States
  • Local Institution - 0201 Boston, Massachusetts, United States
  • Local Institution - 0210 Mineola, New York, United States
View all 122 locations
View Trial Details
Active, not recruiting

A Study of Amivantamab and Lazertinib in Combination With Platinum-Based Chemotherapy Compared With Platinum-Based Chemotherapy in Patients With Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non- Small Cell Lung Cancer After Osimertinib Failure

NCT04988295

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Arizona Oncology Associates Tucson, Arizona, United States
  • City of Hope Duarte, California, United States
  • Cedars Sinai Medical Center Los Angeles, California, United States
View all 249 locations
View Trial Details
Active, not recruiting

THIO Sequenced With Cemiplimab in Advanced NSCLC

NCT05208944

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +14 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Summit Health Florham Park, New Jersey, United States
  • Sunshine Coast Haematology and Oncology Clinic Buderim, Queensland, Australia
  • Cancer Research SA Adelaide, South Australia, Australia
View all 40 locations
View Trial Details
Active, not recruiting

A Study of Dato-DXd in Chinese Patients With Advanced Non-Small Cell Lung Cancer, Triple-negative Breast Cancer and Other Solid Tumors (TROPION-PanTumor02)

NCT05460273

Conditions
Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +13 more
Locations
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Beijing, China
  • Research Site Bengbu, China
View all 21 locations
View Trial Details
Active, not recruiting

A Study of Combination Amivantamab and Carboplatin-Pemetrexed Therapy, Compared With Carboplatin-Pemetrexed, in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Characterized by Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions

NCT04538664

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • City of Hope 2 Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • UCLA Santa Monica, California, United States
  • Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 232 locations
View Trial Details

Related conditions